{"id":7370,"date":"2017-04-30T06:30:04","date_gmt":"2017-04-30T06:30:04","guid":{"rendered":"http:\/\/www.denverpost.com\/?p=2632833"},"modified":"2017-04-30T06:30:04","modified_gmt":"2017-04-30T06:30:04","slug":"father-of-cannabis-research-touts-medicinal-potential-of-cbd-at-pueblo-conference","status":"publish","type":"post","link":"https:\/\/cannitrol.com\/blog\/father-of-cannabis-research-touts-medicinal-potential-of-cbd-at-pueblo-conference\/","title":{"rendered":"\u201cFather of cannabis research\u201d touts medicinal potential of CBD at Pueblo conference"},"content":{"rendered":"<div id=\"wp_fb_like_button\" style=\"margin:5px 0 5px 5px;float:right;height:100px;\"><script src=\"http:\/\/connect.facebook.net\/en_US\/all.js#xfbml=1\"><\/script><fb:like href=\"https:\/\/cannitrol.com\/blog\/father-of-cannabis-research-touts-medicinal-potential-of-cbd-at-pueblo-conference\/\" send=\"true\" layout=\"standard\" width=\"450\" show_faces=\"false\" font=\"arial\" action=\"like\" colorscheme=\"light\"><\/fb:like><\/div><p>PUEBLO \u2014 If the United States stopped viewing CBD as an illegal substance, it would unlock the marijuana compound\u2019s immense potential as medicine, the \u201cfather of cannabis research\u201d said Saturday.<\/p>\n<p><a href=\"http:\/\/medicine.ekmd.huji.ac.il\/en\/publications\/researchersPages\/pages\/raphaelm.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">Raphael Mechoulam<\/a>, a Hebrew University professor and organic chemist with <a href=\"http:\/\/www.thecannabist.co\/2016\/09\/28\/israel-cannabis-research\/63987\/\">six decades of research on cannabis<\/a>, was in Colorado to serve as the keynote speaker for the inaugural conference of the Colorado State University-Pueblo\u2019s Institute for Cannabis Research.<\/p>\n<p>\u201cI believe that CBD has to be moved from the highest illegal situation next to heroin, which doesn\u2019t make sense, because it\u2019s not toxic, doesn\u2019t cause any addiction, so it should be moved,\u201d Mechoulam said to The Denver Post and The Cannabist in a brief interview following his speech. \u201cAnd once it\u2019s moved, more people will be using it. And I hope it will become a major (medicinal) drug.\u201d<\/p>\n<p>Mechoulam\u2019s hour-long speech focused on his research, an extensive collection that includes roughly 400 scientific articles cited nearly 100,000 times. Mechoulam is credited for the discovery of the endocannabinoid system and the isolation, determination of chemical composition and structure, and synthesis of the major cannabinoids \u2013 notably CBD, delta-9 tetrahydrocannabinol and cannabigerol (CBG).<\/p>\n<p>Mechoulam highlighted\u00a0some of his team\u2019s findings over the years including: delta-8 tetrahydrocannabinol <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7776837\" target=\"_blank\" rel=\"noopener noreferrer\">was shown to prevent<\/a> vomiting and other side effects of chemotherapy in children with cancer; <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/17714746\/\" target=\"_blank\" rel=\"noopener noreferrer\">hinder the onset<\/a> of Type 1 diabetes in mice; and serve as an anti-psychotic for patients with schizophrenia.<\/p>\n<p>The research is there and, in some cases, has been there for decades, he said.<\/p>\n<p>Now it\u2019s a matter of somebody putting the findings to use and advancing the science into medicine.<\/p>\n<p>\u201cIt should be done \u2026 but unfortunately, nothing is happening at the moment,\u201d Mechoulam said.<\/p>\n<aside class=\"related right\" \/>\n<p>Clinical trials are costly and those in academia don\u2019t have the ability or the resources to take those next steps, he said, adding that he\u2019s been \u201cwaiting for about 10 years\u201d for a pharmaceutical company or other significantly sized entity to conduct a clinical trial on the effectiveness of CBD in the prevention and treatment of Type 1 diabetes.<\/p>\n<p>\u201cIt\u2019s a pity because in this particular case, diabetes type 1, it\u2019s not different \u2026 in mice and in humans,\u201d he said. \u201cSo here we\u2019re missing something. I hope, one of these days, somebody will do a clinical trial and show, I hope, that one can treat diabetes type 1 with cannabidiol with essentially no side-effects.\u201d<\/p>\n<p>U.S. Drug Enforcement Administration officials <a href=\"http:\/\/www.thecannabist.co\/2016\/12\/15\/dea-cbd-new-rule-marijuana-extracts\/69550\/\">consider cannabidiol (CBD) and other marijuana extracts as Schedule I<\/a> substances, the strictest of the classifications; however, that policy position is being challenged in an <a href=\"http:\/\/www.thecannabist.co\/2017\/04\/05\/hemp-lawsuit-federal-court-dea-rule-marijuana-extracts\/76635\/\">ongoing federal appeals court case<\/a>.<\/p>\n<p>The newly formed <a href=\"https:\/\/www.csupueblo.edu\/institute-of-cannabis-research\/2017-conference\/\" target=\"_blank\" rel=\"noopener noreferrer\">Institute of Cannabis Research\u2019s<\/a> three-day conference attracted 550 attendees from 10 countries and 21 U.S. states. The event\u2019s discussion panels spanned an array of topics such as research, taxation, real estate, medicine, health and business.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PUEBLO &#8212; If the United States stopped viewing CBD as an illegal substance, it would unlock the marijuana compound\u2019s immense potential as medicine, the \u201cfather of cannabis research\u201d said Saturday. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[531,330,6811,6813,77,56,9,5019,1,3,61,1736],"tags":[3105,2908,6816,6818,2655,2636,5022],"_links":{"self":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/7370"}],"collection":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/comments?post=7370"}],"version-history":[{"count":0,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/7370\/revisions"}],"wp:attachment":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/media?parent=7370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/categories?post=7370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/tags?post=7370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}